Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Celebrating the ACP centennial: from the Annals archive.

Cotton D.

Ann Intern Med. 2015 Jan 6;162(1):70. doi: 10.7326/M14-2654. No abstract available.

PMID:
25560715
2.

Summaries for patients. Multitarget therapy for induction treatment of lupus nephritis.

[No authors listed]

Ann Intern Med. 2015 Jan 6;162(1):I24. doi: 10.7326/P15-9000. No abstract available.

PMID:
25383607
3.

Treatment of lupus nephritis--a work in progress.

Falk RJ.

N Engl J Med. 2000 Oct 19;343(16):1182-3. No abstract available.

PMID:
11036127
4.

Lupus nephritis: Multitarget induction therapy for LN.

Allison SJ.

Nat Rev Nephrol. 2015 Jan;11(1):3. doi: 10.1038/nrneph.2014.225. Epub 2014 Nov 25. No abstract available.

PMID:
25421833
5.

[Pharmacotherapy of SLE].

Nakazawa T, Kumagai S, Kogata Y.

Nihon Rinsho. 2005 May;63 Suppl 5:253-9. Review. Japanese. No abstract available.

PMID:
15954358
6.

[Treatment with immunosuppressive agents in disseminated lupus erythematosus and in some evolutive nephropathies].

Purice S, Ghelerter L, Matei I, Brunazian G.

Stud Cercet Med Interna. 1969;10(2):147-53. Romanian. No abstract available.

PMID:
5344004
7.

Induction therapy for active lupus nephritis: mycophenolate mofetil versus cyclophosphamide.

Burchardi C, Schlöndorff D.

Nat Clin Pract Nephrol. 2006 Jun;2(6):314-5. No abstract available.

PMID:
16932452
8.

[Interdisciplinary consensus to management of lupus nephritis in Germany].

de Groot K.

Z Rheumatol. 2007 Dec;66(8):724, 726. German.

PMID:
17965864
9.

Sequential therapies for proliferative lupus nephritis.

Farhey Y, Hess E.

N Engl J Med. 2004 Jun 10;350(24):2518-20; author reply 2518-20. No abstract available.

PMID:
15195342
10.

Maintenance therapy for lupus nephritis--something old, something new.

Balow JE, Austin HA 3rd.

N Engl J Med. 2004 Mar 4;350(10):1044-6. No abstract available.

PMID:
14999117
11.

Immunosuppressive agents in lupus nephritis: a critical analysis.

Wagner L.

Medicine (Baltimore). 1976 May;55(3):239-50. Review. No abstract available.

PMID:
775253
12.

Multitarget therapy for induction treatment of lupus nephritis: a randomized trial.

Liu Z, Zhang H, Liu Z, Xing C, Fu P, Ni Z, Chen J, Lin H, Liu F, He Y, He Y, Miao L, Chen N, Li Y, Gu Y, Shi W, Hu W, Liu Z, Bao H, Zeng C, Zhou M.

Ann Intern Med. 2015 Jan 6;162(1):18-26. doi: 10.7326/M14-1030.

PMID:
25383558
13.

[Mycophenolate mofetil in lupus nephritis treatment].

Savio V, Alba P, Babini AM.

Rev Fac Cien Med Univ Nac Cordoba. 2012;69(4):219-23. Review. Spanish. No abstract available.

PMID:
23751789
14.

Immunosuppressive therapies for the induction treatment of proliferative lupus nephritis: a systematic review and network metaanalysis.

Tian SY, Feldman BM, Beyene J, Brown PE, Uleryk EM, Silverman ED.

J Rheumatol. 2014 Oct;41(10):1998-2007. doi: 10.3899/jrheum.140050. Epub 2014 Sep 15. Review.

PMID:
25225281
15.

Current management of lupus nephritis.

Houssiau FA, Lauwerys BR.

Best Pract Res Clin Rheumatol. 2013 Jun;27(3):319-28. doi: 10.1016/j.berh.2013.07.004. Review.

PMID:
24238689
16.

Infantile systemic lupus erythematosus presenting with pulmonary hemorrhage.

Kreindler J, Ellis D, Vats A, Kurland G, Ranganathan S, Moritz ML.

Pediatr Nephrol. 2005 Apr;20(4):522-5. Epub 2005 Feb 17.

PMID:
15717168
17.

Mycophenolate mofetil for lupus nephritis: an update.

Mok CC.

Expert Rev Clin Immunol. 2015;11(12):1353-64. doi: 10.1586/1744666X.2015.1087314. Epub 2015 Sep 12. Review.

PMID:
26364748
18.

How did cyclophosphamide become the drug of choice for lupus nephritis?

Bargman JM.

Nephrol Dial Transplant. 2009 Feb;24(2):381-4. doi: 10.1093/ndt/gfn640. Epub 2008 Dec 4. Review. No abstract available.

PMID:
19056783
19.

Sequential therapies for proliferative lupus nephritis.

Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E, O'Nan P, Roth D.

N Engl J Med. 2004 Mar 4;350(10):971-80.

20.

Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis.

Karassa FB, Isenberg DA.

N Engl J Med. 2001 Feb 1;344(5):382-3. No abstract available. Erratum in: N Engl J Med 2001 Apr 12;344(15):1176.

PMID:
11195799

Supplemental Content

Support Center